-segment lesions within the SFA for patients
with claudication, although their superiority to BMSs is
as yet unproven. The Viabahn Endoprosthesis with
PROPATEN Bioactive Surface (VIA) vs Bare Nitinol
Stent in the Treatment of Long Lesions in SuperÔ¨Åcial
Femoral Artery Occlusive Disease (VIASTAR) prospective
multicenter trial213 compared BMSs with heparin